Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 42 clinical trials
MIBG Therapy for Patients With MIBG Avid Tumors

radiopharmaceutical that concentrates within adrenomedullary tissue. The agent was initially used for tumor imaging due to its capability to locate pheochromocytomas, neuroblastomas and other neuroendocrine tumors

  • 2 views
  • 03 Jun, 2021
  • 1 location
Intravenous Metoclopramide for the Treatment of Post Concussive Headache: a Randomized Placebo Controlled Trial

Concussion is defined as any temporary disturbance in brain function following a blow to the head. It may not involve a loss of consciousness and usually results in a post concussive headache (PCH) immediately after the injury. Between 30 and 50 percent of patients with concussion will develop postconcussive syndrome …

metoclopramide
amnesia
headache
confusion
  • 22 views
  • 07 Nov, 2020
  • 1 location
Diagnosis of Pheochromocytoma

The goal of this study is to develop better methods of diagnosis, localization, and treatment for pheochromocytomas. These tumors, which usually arise from the adrenal glands, are often

18f-fdg
adrenal pheochromocytoma
somatostatin
clonidine
chromogranin a
  • 16 views
  • 05 Sep, 2021
  • 2 locations
Multicenter Pheochromocytoma and Paraganglioma Evaluation

Target population: Patients with (1) newly diagnosed or (2) past history of pheochromocytomas and paragangliomas (PPGL) or (3) carrier of genetic mutations in known PPGL susceptibility

pheochromocytoma
adrenal pheochromocytoma
special care
paraganglioma
  • 36 views
  • 24 Jan, 2021
  • 1 location
Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs

This is a multicenter, open-label, single-arm study to evaluate the safety and dosimetry of Lutathera in adolescent patients 12 to <18 years old with somatostatin receptor positive GEP-NETs and PPGLs. The study will enroll at least 8 patients in the GEP-NET cohort and as many adolescents with PPGL as possible …

metastatic disease
somatostatin
dotatate
  • 0 views
  • 12 Sep, 2021
  • 19 locations
A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma or Malignant Pheochromocytoma/Paraganglioma

Pheochromocytoma/Paraganglioma.

metastasis
adrenal pheochromocytoma
therapeutic vaccine
pheochromocytoma
metastatic disease
  • 10 views
  • 26 Jul, 2021
  • 10 locations
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL) or Pancreatic Neuroendocrine Tumor (pNET) (MK-6482-015)

This is a study to evaluate the efficacy and safety of Belzutifan monotherapy in participants with advanced pheochromocytoma/paraganglioma (PPGL) or pancreatic neuroendocrine tumor (pNET). The

  • 0 views
  • 15 Sep, 2021
  • 13 locations
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

: Endocrine carcinoma of pancreas and digestive tract.) (closed to accrual) Neuroendocrine carcinoma including carcinoid of the lung (closed to accrual 12/19/2017) Pheochromocytoma

hysterectomy
peritoneal mesothelioma
immunosuppressive agents
adrenal tumor
lepidic predominant adenocarcinoma
  • 6048 views
  • 16 Sep, 2021
  • 818 locations
Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors

Background People with von Hippel-Lindau (VHL) can have problems with a variety of organs, such as the pancreas. The disease can cause tumors of the pancreas. This can result in life-threatening complications. Researchers want to learn more about these pancreatic tumors and how to better detect them. This may help …

genetic testing
ct scan
cyst
neuroendocrine tumor
dotatate
  • 0 views
  • 12 Sep, 2021
  • 1 location
18F-DOPA II - PET Imaging Optimization

A single centre non-randomized, non-blinded phase III prospective cohort study of 18F-DOPA PET/CT imaging in specific patient populations: Pediatric patients (less than 18 years old) with congenital hyperinsulinism. Pediatric patients (less than 18 years old) with neuroblastoma. Pediatric (less than 18 years old) or Adult patients (18 or older) with …

  • 0 views
  • 29 Apr, 2021
  • 1 location